Title : A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan - Chang_2019_Adv.Ther_36_1455 |
Author(s) : Chang CC , Peng GS , Lai TJ , Li CH , Liu CK |
Ref : Adv Ther , 36 :1455 , 2019 |
Abstract : |
PubMedSearch : Chang_2019_Adv.Ther_36_1455 |
PubMedID: 30953330 |
Title : Real-world evaluation of compliance and preference in Alzheimer's disease treatment: an observational study in Taiwan - Lai_2016_Patient.Prefer.Adherence_10_383 |
Author(s) : Lai TH , Wang WF , Yip BS , Yang YW , Peng GS , Tsai SJ , Liao YC , Pai MC |
Ref : Patient Prefer Adherence , 10 :383 , 2016 |
Abstract : |
PubMedSearch : Lai_2016_Patient.Prefer.Adherence_10_383 |
PubMedID: 27099476 |